Literature DB >> 16393765

Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register.

S Odegård1, A Finset, T K Kvien, P Mowinckel, T Uhlig.   

Abstract

OBJECTIVE: To explore the prevalence of work disability (WD) and to identify bio-psychological factors that predicts future WD in rheumatoid arthritis (RA) over a 7-year period.
METHODS: Patients were selected from the Oslo RA register. The prevalence of WD was studied cross-sectionally among respondents <67 years (n = 526) in a postal survey. Mean age (SD) was 51.1 (11.9) years, mean disease duration 11.3 (9.4) years, and 49% of patients were RF-positive. The patients studied for predictive factors for WD were respondents in postal surveys both at baseline and at the 7-year follow-up, in work at baseline and still in working age (<67 years) at follow-up (n = 159). Mean age at baseline (SD) was 44.5 (9.7) years, mean disease duration 8.4 (6.6) years, mean years of formal education 12.7 (3.1) years, 48% were RF-positive. Assessments included socio-demographic variables and health status measures (MHAQ, AIMS2, SF-36, fatigue and pain on VAS 0-100 mm, self efficacy, and RAI as a measure for helplessness).
RESULTS: Among the 526 respondents at baseline <67 years, the prevalence of WD was 40%. A high level of education was a predictor of reduced risk of work disability [odds ratio (OR) = 0.4, 95% confidence interval (CI) 0.1; 0.9], while female gender (OR 3.0, 95% CI 1.1; 8.0), physical disability (MHAQ-score) (OR = 3.9, 95% CI 1.2; 12.5) and helplessness over median RAI-score (OR = 3.0, 95% CI 1.4; 6.7) were independent predictors of increased risk for new work disability over 7 years.
CONCLUSION: Physical disability, increased helplessness, low formal education, and female gender were found to be independent risk factors for new work disability over the 7-year study period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16393765     DOI: 10.1080/03009740510018633

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  30 in total

1.  Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.

Authors:  Roozbeh Sharif; Maureen D Mayes; Perry M Nicassio; Emilio B Gonzalez; Hilda Draeger; Terry A McNearney; Rosa M Estrada-Y-Martin; Deepthi K Nair; John D Reveille; Frank C Arnett; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2011-03-22       Impact factor: 5.532

2.  Reliability of the ICF Core Set for rheumatoid arthritis.

Authors:  Till Uhlig; Solvår Lillemo; Rikke Helene Moe; Tanja Stamm; Alarcos Cieza; Annelies Boonen; Petter Mowinckel; Tore Kristian Kvien; Gerold Stucki
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 3.  Pain, catastrophizing, and depression in the rheumatic diseases.

Authors:  Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

4.  The burden of disease in rheumatoid arthritis.

Authors:  Till Uhlig; Rikke H Moe; Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

Review 5.  Psychological approaches to understanding and treating arthritis pain.

Authors:  Francis J Keefe; Tamara J Somers
Journal:  Nat Rev Rheumatol       Date:  2010-04       Impact factor: 20.543

Review 6.  Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Authors:  Jasvinder A Singh; Alomgir Hossain; Amy S Mudano; Elizabeth Tanjong Ghogomu; Maria E Suarez-Almazor; Rachelle Buchbinder; Lara J Maxwell; Peter Tugwell; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

7.  Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Theodore Pincus; Suzanne M M Verstappen; Amita Aggarwal; Rieke Alten; Daina Andersone; Humeira Badsha; Eva Baecklund; Miguel Belmonte; Jürgen Craig-Müller; Licia Maria Henrique da Mota; Alexander Dimic; Nihal A Fathi; Gianfranco Ferraccioli; Wataru Fukuda; Pál Géher; Feride Gogus; Najia Hajjaj-Hassouni; Hisham Hamoud; Glenn Haugeberg; Dan Henrohn; Kim Horslev-Petersen; Ruxandra Ionescu; Dmitry Karateew; Reet Kuuse; Ieda Maria Magalhaes Laurindo; Juris Lazovskis; Reijo Luukkainen; Ayman Mofti; Eithne Murphy; Ayako Nakajima; Omondi Oyoo; Sapan C Pandya; Christof Pohl; Denisa Predeteanu; Mjellma Rexhepi; Sylejman Rexhepi; Banwari Sharma; Eisuke Shono; Jean Sibilia; Stanislaw Sierakowski; Fotini N Skopouli; Sigita Stropuviene; Sergio Toloza; Ivo Valter; Anthony Woolf; Hisashi Yamanaka
Journal:  Arthritis Res Ther       Date:  2010-03-12       Impact factor: 5.156

8.  Which patients with rheumatoid arthritis are still working?

Authors:  Till Uhlig
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

9.  Paid work is associated with improved health-related quality of life in patients with rheumatoid arthritis.

Authors:  Kjersti Grønning; Erik Rødevand; Aslak Steinsbekk
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

10.  A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

Authors:  Jasvinder A Singh; Robin Christensen; George A Wells; Maria E Suarez-Almazor; Rachelle Buchbinder; Maria Angeles Lopez-Olivo; Elizabeth Tanjong Ghogomu; Peter Tugwell
Journal:  CMAJ       Date:  2009-11-02       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.